Lantern Pharma Inc. Quarterly Weighted Average Number of Shares Outstanding, Basic from Q1 2021 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Lantern Pharma Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q1 2021 to Q2 2024.
  • Lantern Pharma Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending June 30, 2024 was 10.8M shares, a 0.91% decline year-over-year.
  • Lantern Pharma Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 10.8M shares, a 0.08% decline from 2022.
  • Lantern Pharma Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 10.9M shares, a 0.5% decline from 2021.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 10.8M -98.2K -0.91% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 10.7M -114K -1.05% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 10.8M -8.21K -0.08% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-18
Q3 2023 10.9M +18.5K +0.17% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-08
Q2 2023 10.9M +26.1K +0.24% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 10.9M -18.7K -0.17% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 10.9M -54.3K -0.5% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-18
Q3 2022 10.8M -347K -3.11% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-08
Q2 2022 10.8M -351K -3.14% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-09
Q1 2022 10.9M +801K +7.95% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q4 2021 10.9M Oct 1, 2021 Dec 31, 2021 10-K 2023-03-20
Q3 2021 11.2M Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-07
Q2 2021 11.2M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-08
Q1 2021 10.1M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-03
* An asterisk sign (*) next to the value indicates that the value is likely invalid.